Presenting at Piper Jaffray Healthcare Conference

GW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference on 29 November

London, UK, 22 November 2016:GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference on Tuesday, 29 November 2016, at 10:30 a.m. ET at the Lotte New York Palace, New York City.

A live audio webcast of the presentation will be available through GW’s corporate website in the investor relations section from the investor’s calendar of events page at www.gwpharm.com. A replay will be available soon after the live presentation.

About GW

... read more at: http://www.lse.co.uk/regulatory-news-article.asp?ArticleCode=il6sq5eg&ArticleHeadline=Presenting_at_Piper_Jaffray_Healthcare_Conference

by